16. Generative AI in Medical Affairs: Real Use Cases from Merck, Pfizer & Astellas
About this episode
Industry leaders discuss real-world applications of Generative AI in Medical Affairs.
Following a standing-room-only session at the 2025 MAPS Annual Meeting, Acceleration Point CEO Scott Thompson sits down with three industry leaders who are shaping how Generative AI is being applied inside Medical Affairs today—not in theory, but in practice. Wendy Fraser (Merck), Annamaria Crisan (Pfizer), and Rishi Ohri (Astellas Pharma) share real-world examples, critical lessons, and hard-won truths from piloting Gen AI across Field Medical teams, Medical Information, HEOR, and Omnichannel. They discuss personal productivity, process improvement, clinical risks, compliance pitfalls, and how to build trust—both with your technology and your teams. If you’re exploring how to scale Gen AI within a regulated environment, this is your roadmap.
Topics covered
- Generative AI
- Medical Affairs
- Field Medical teams
- Medical Information
- HEOR
- Omnichannel
Keywords
- Generative AI
- Medical Affairs
- productivity
- process improvement
- clinical risks
- compliance
- trust
More episodes of OnPoint: The Medical Excellence Podcast
- The Glue That Holds It Together: Craig Granowitz on the Real Role of Medical Affairs
- 22. AI Adoption in Medical Affairs: What High-Performing Teams Do Differently
- 21. 2025 Year in Review: Six Trends Reshaping Medical Affairs
- 20. Omnichannel at Scale: Redefining Medical Engagement
- 19. Transforming Medical Affairs at Amicus Therapeutics
- 18. Measuring Medical Affairs Impact with Paul Minne
Explore listener stats, chart rankings, contacts and more on the OnPoint: The Medical Excellence Podcast podcast page.